Frederick M. Dirbas

8.7k total citations · 2 hit papers
66 papers, 3.7k citations indexed

About

Frederick M. Dirbas is a scholar working on Cancer Research, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Frederick M. Dirbas has authored 66 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Cancer Research, 21 papers in Surgery and 20 papers in Pathology and Forensic Medicine. Recurrent topics in Frederick M. Dirbas's work include Breast Cancer Treatment Studies (23 papers), Breast Lesions and Carcinomas (19 papers) and Breast Implant and Reconstruction (12 papers). Frederick M. Dirbas is often cited by papers focused on Breast Cancer Treatment Studies (23 papers), Breast Lesions and Carcinomas (19 papers) and Breast Implant and Reconstruction (12 papers). Frederick M. Dirbas collaborates with scholars based in United States, Netherlands and Israel. Frederick M. Dirbas's co-authors include Maider Zabala, Dalong Qian, Michael F. Clarke, Neethan A. Lobo, George Somlo, Kaiqin Lao, Piero Dalerba, Yohei Shimono, Renee A. Reijo Pera and Maximilian Diehn and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Frederick M. Dirbas

63 papers receiving 3.7k citations

Hit Papers

Downregulation of miRNA-200c Links Breast Cancer Stem Cel... 2009 2026 2014 2020 2009 2020 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Downregulation of miRNA-200c Links Breast Cancer Stem Cells with Normal Stem Cells
    2009 971 citations Yohei Shimono, Maider Zabala et al. Cell profile →
  2. Single-cell transcriptional diversity is a hallmark of developmental potential
    2020 712 citations Gunsagar S. Gulati, Shaheen S. Sikandar et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frederick M. Dirbas United States 26 1.7k 1.5k 1.2k 592 576 66 3.7k
Reinhard Horvat Austria 40 1.8k 1.1× 1.0k 0.7× 1.4k 1.2× 544 0.9× 631 1.1× 106 4.2k
Gudrun E. Koehl Germany 28 1.9k 1.1× 615 0.4× 1.2k 1.0× 599 1.0× 682 1.2× 44 4.0k
Deborah Dillon United States 32 1.5k 0.9× 829 0.5× 1.5k 1.3× 361 0.6× 332 0.6× 87 3.7k
Kenjiro Sawada Japan 40 2.7k 1.6× 1.5k 1.0× 1.3k 1.1× 1.0k 1.7× 310 0.5× 137 5.0k
Cécile Colpaert Belgium 33 1.0k 0.6× 1.0k 0.7× 1.6k 1.4× 292 0.5× 412 0.7× 92 3.6k
Julie K. Schwarz United States 37 2.1k 1.3× 1.1k 0.7× 1.6k 1.4× 570 1.0× 623 1.1× 134 5.0k
W. Böcker Germany 38 1.8k 1.0× 890 0.6× 1.3k 1.1× 366 0.6× 918 1.6× 183 4.7k
Yutaka Yamamoto Japan 36 1.6k 0.9× 1.7k 1.1× 1.7k 1.5× 304 0.5× 292 0.5× 194 3.9k
Frank Weber Germany 37 1.9k 1.1× 938 0.6× 910 0.8× 344 0.6× 633 1.1× 125 4.1k
Vincent A. Memoli United States 41 1.9k 1.1× 1.5k 1.0× 1.6k 1.4× 366 0.6× 558 1.0× 124 4.8k

Countries citing papers authored by Frederick M. Dirbas

Since Specialization
Citations

This map shows the geographic impact of Frederick M. Dirbas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frederick M. Dirbas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frederick M. Dirbas more than expected).

Fields of papers citing papers by Frederick M. Dirbas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frederick M. Dirbas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frederick M. Dirbas. The network helps show where Frederick M. Dirbas may publish in the future.

Co-authorship network of co-authors of Frederick M. Dirbas

This figure shows the co-authorship network connecting the top 25 collaborators of Frederick M. Dirbas. A scholar is included among the top collaborators of Frederick M. Dirbas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frederick M. Dirbas. Frederick M. Dirbas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Melemenidis, Stavros, Vignesh Viswanathan, Suparna Dutt, et al.. (2025). Effectiveness of FLASH vs. Conventional Dose Rate Radiotherapy in a Model of Orthotopic, Murine Breast Cancer. Cancers. 17(7). 1095–1095. 1 indexed citations
2.
Margenthaler, Julie, Youssef H. Zeidan, Rosa Di Micco, et al.. (2025). 2101 Local management of second breast cancer event after primary breast conserving therapy: International DELPHI consensus. Radiotherapy and Oncology. 206. S508–S509.
3.
Hui, Caressa, Frederick M. Dirbas, & Kathleen C. Horst. (2023). Management of Local–Regional Recurrence of Breast Cancer. Current Breast Cancer Reports. 15(3). 185–195.
4.
5.
Sikandar, Shaheen S., Gunsagar S. Gulati, Jane Antony, et al.. (2022). Identification of a minority population of LMO2 + breast cancer cells that integrate into the vasculature and initiate metastasis. Science Advances. 8(45). eabm3548–eabm3548. 3 indexed citations
6.
Zabala, Maider, Neethan A. Lobo, Jane Antony, et al.. (2020). LEFTY1 Is a Dual-SMAD Inhibitor that Promotes Mammary Progenitor Growth and Tumorigenesis. Cell stem cell. 27(2). 284–299.e8. 12 indexed citations
7.
8.
Gulati, Gunsagar S., Shaheen S. Sikandar, Daniel J. Wesche, et al.. (2020). Single-cell transcriptional diversity is a hallmark of developmental potential. Science. 367(6476). 405–411. 712 indexed citations breakdown →
9.
Beausang, John F., et al.. (2017). T cell receptor sequencing of early-stage breast cancer tumors identifies altered clonal structure of the T cell repertoire. Proceedings of the National Academy of Sciences. 114(48). E10409–E10417. 46 indexed citations
10.
Hah, Jennifer M., Sean Mackey, Peter Schmidt, et al.. (2017). Effect of Perioperative Gabapentin on Postoperative Pain Resolution and Opioid Cessation in a Mixed Surgical Cohort. JAMA Surgery. 153(4). 303–303. 139 indexed citations
11.
Wang, Lei, Andrea K. Miyahira, Diana L. Simons, et al.. (2016). IL6 Signaling in Peripheral Blood T Cells Predicts Clinical Outcome in Breast Cancer. Cancer Research. 77(5). 1119–1126. 37 indexed citations
12.
Horst, Kathleen C., Carolina E. Fasola, Debra M. Ikeda, et al.. (2016). Five-year results of a prospective clinical trial investigating accelerated partial breast irradiation using 3D conformal radiotherapy after lumpectomy for early stage breast cancer. The Breast. 28. 178–183. 8 indexed citations
13.
Horst, Kathleen C., Katherine E. Fero, Debra M. Ikeda, Bruce L. Daniel, & Frederick M. Dirbas. (2013). Defining an optimal role for breast magnetic resonance imaging when evaluating patients otherwise eligible for accelerated partial breast irradiation. Radiotherapy and Oncology. 108(2). 220–225. 8 indexed citations
14.
Horst, Kathleen C., Debra M. Ikeda, Katherine E. Fero, et al.. (2012). Breast Magnetic Resonance Imaging Alters Patient Selection for Accelerated Partial Breast Irradiation. American Journal of Clinical Oncology. 37(3). 248–254. 9 indexed citations
15.
Yu, Hongxiang, Diana L. Simons, Erich Schwartz, et al.. (2012). PRC2/EED-EZH2 Complex Is Up-Regulated in Breast Cancer Lymph Node Metastasis Compared to Primary Tumor and Correlates with Tumor Proliferation In Situ. PLoS ONE. 7(12). e51239–e51239. 50 indexed citations
16.
Shimono, Yohei, Maider Zabala, Robert W. Cho, et al.. (2009). Downregulation of miRNA-200c Links Breast Cancer Stem Cells with Normal Stem Cells. Cell. 138(3). 592–603. 971 indexed citations breakdown →
17.
Cox, Brett, Kathleen C. Horst, Brian Thorndyke, et al.. (2005). Respiratory Gating During Accelerated Partial Breast Irradiation (APBI) Permits Reduced Planning Tumor Volumes and Improved Normal Tissue Dose Distributions. International Journal of Radiation Oncology*Biology*Physics. 63. S249–S249. 1 indexed citations
18.
Dirbas, Frederick M., Stefanie S. Jeffrey, & Don R. Goffinet. (2004). The Evolution of Accelerated, Partial Breast Irradiation as a Potential Treatment Option for Women with Newly Diagnosed Breast Cancer Considering Breast Conservation. Cancer Biotherapy and Radiopharmaceuticals. 19(6). 673–705. 7 indexed citations
19.
Daniel, Bruce L., Robyn L. Birdwell, Kim Butts, et al.. (2001). Freehand iMRI‐guided large‐gauge core needle biopsy: A new minimally invasive technique for diagnosis of enhancing breast lesions. Journal of Magnetic Resonance Imaging. 13(6). 896–902. 37 indexed citations
20.
Parenteau, Gary L., Frederick M. Dirbas, Kayhan Garmestani, et al.. (1992). PROLONGATION OF GRAFT SURVIVAL IN PRIMATE ALLOGRAFT TRANSPLANTATION BY YTTRIUM-90-LABELED ANTI-TAC IN CONJUNCTION WITH GRANULOCYTE COLONY-STIMULATING FACTOR. Transplantation. 54(6). 963–968. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Reinhard Horvat Breakdown of academic impact, for papers by Gudrun E. Koehl Breakdown of academic impact, for papers by Deborah Dillon Breakdown of academic impact, for papers by Kenjiro Sawada Breakdown of academic impact, for papers by Cécile Colpaert Breakdown of academic impact, for papers by Julie K. Schwarz Breakdown of academic impact, for papers by W. Böcker Breakdown of academic impact, for papers by Yutaka Yamamoto Breakdown of academic impact, for papers by Frank Weber Breakdown of academic impact, for papers by Vincent A. Memoli
Rankless by CCL
2026